Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging

Fig. 3

Agreement between measurements on contrast-enhanced spectral mammography (CESM) and magnetic resonance imaging (MRI) at each step of the study. Agreement (Lin’s coefficient) for measurement of tumor sizes using CESM and MRI (mm), respectively, before the beginning of (pre-NAC), during (during-NAC) and after the end of (post-NAC) neoadjuvant chemotherapy just before surgery. Progressive dimensional shrinkage and a difference between measurement sets using the two diagnostic tools can be observed

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us